A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristics.

The benefit of routine HIV-1 viral load (VL) monitoring of patients on antiretroviral therapy (ART) in resource-constrained settings is uncertain because of the high costs associated with the test and the limited treatment options. We designed a cluster randomized controlled trial to compare the use...

Full description

Bibliographic Details
Main Authors: John R Koethe, Andrew O Westfall, Dora K Luhanga, Gina M Clark, Jason D Goldman, Priscilla L Mulenga, Ronald A Cantrell, Benjamin H Chi, Isaac Zulu, Michael S Saag, Jeffrey S A Stringer
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-03-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2837376?pdf=render
id doaj-892dbe4148114cf48a5337129038c0b4
record_format Article
spelling doaj-892dbe4148114cf48a5337129038c0b42020-11-25T01:51:49ZengPublic Library of Science (PLoS)PLoS ONE1932-62032010-03-0153e968010.1371/journal.pone.0009680A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristics.John R KoetheAndrew O WestfallDora K LuhangaGina M ClarkJason D GoldmanPriscilla L MulengaRonald A CantrellBenjamin H ChiIsaac ZuluMichael S SaagJeffrey S A StringerThe benefit of routine HIV-1 viral load (VL) monitoring of patients on antiretroviral therapy (ART) in resource-constrained settings is uncertain because of the high costs associated with the test and the limited treatment options. We designed a cluster randomized controlled trial to compare the use of routine VL testing at ART-initiation and at 3, 6, 12, and 18 months, versus our local standard of care (which uses immunological and clinical criteria to diagnose treatment failure, with discretionary VL testing when the two do not agree).Dedicated study personnel were integrated into public-sector ART clinics. We collected participant information in a dedicated research database. Twelve ART clinics in Lusaka, Zambia constituted the units of randomization. Study clinics were stratified into pairs according to matching criteria (historical mortality rate, size, and duration of operation) to limit the effect of clustering, and independently randomized to the intervention and control arms. The study was powered to detect a 36% reduction in mortality at 18 months.From December 2006 to May 2008, we completed enrollment of 1973 participants. Measured baseline characteristics did not differ significantly between the study arms. Enrollment was staggered by clinic pair and truncated at two matched sites.A large clinical trial of routing VL monitoring was successfully implemented in a dynamic and rapidly growing national ART program. Close collaboration with local health authorities and adequate reserve staff were critical to success. Randomized controlled trials such as this will likely prove valuable in determining long-term outcomes in resource-constrained settings.Clinicaltrials.gov NCT00929604.http://europepmc.org/articles/PMC2837376?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author John R Koethe
Andrew O Westfall
Dora K Luhanga
Gina M Clark
Jason D Goldman
Priscilla L Mulenga
Ronald A Cantrell
Benjamin H Chi
Isaac Zulu
Michael S Saag
Jeffrey S A Stringer
spellingShingle John R Koethe
Andrew O Westfall
Dora K Luhanga
Gina M Clark
Jason D Goldman
Priscilla L Mulenga
Ronald A Cantrell
Benjamin H Chi
Isaac Zulu
Michael S Saag
Jeffrey S A Stringer
A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristics.
PLoS ONE
author_facet John R Koethe
Andrew O Westfall
Dora K Luhanga
Gina M Clark
Jason D Goldman
Priscilla L Mulenga
Ronald A Cantrell
Benjamin H Chi
Isaac Zulu
Michael S Saag
Jeffrey S A Stringer
author_sort John R Koethe
title A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristics.
title_short A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristics.
title_full A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristics.
title_fullStr A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristics.
title_full_unstemmed A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristics.
title_sort cluster randomized trial of routine hiv-1 viral load monitoring in zambia: study design, implementation, and baseline cohort characteristics.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2010-03-01
description The benefit of routine HIV-1 viral load (VL) monitoring of patients on antiretroviral therapy (ART) in resource-constrained settings is uncertain because of the high costs associated with the test and the limited treatment options. We designed a cluster randomized controlled trial to compare the use of routine VL testing at ART-initiation and at 3, 6, 12, and 18 months, versus our local standard of care (which uses immunological and clinical criteria to diagnose treatment failure, with discretionary VL testing when the two do not agree).Dedicated study personnel were integrated into public-sector ART clinics. We collected participant information in a dedicated research database. Twelve ART clinics in Lusaka, Zambia constituted the units of randomization. Study clinics were stratified into pairs according to matching criteria (historical mortality rate, size, and duration of operation) to limit the effect of clustering, and independently randomized to the intervention and control arms. The study was powered to detect a 36% reduction in mortality at 18 months.From December 2006 to May 2008, we completed enrollment of 1973 participants. Measured baseline characteristics did not differ significantly between the study arms. Enrollment was staggered by clinic pair and truncated at two matched sites.A large clinical trial of routing VL monitoring was successfully implemented in a dynamic and rapidly growing national ART program. Close collaboration with local health authorities and adequate reserve staff were critical to success. Randomized controlled trials such as this will likely prove valuable in determining long-term outcomes in resource-constrained settings.Clinicaltrials.gov NCT00929604.
url http://europepmc.org/articles/PMC2837376?pdf=render
work_keys_str_mv AT johnrkoethe aclusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics
AT andrewowestfall aclusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics
AT dorakluhanga aclusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics
AT ginamclark aclusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics
AT jasondgoldman aclusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics
AT priscillalmulenga aclusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics
AT ronaldacantrell aclusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics
AT benjaminhchi aclusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics
AT isaaczulu aclusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics
AT michaelssaag aclusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics
AT jeffreysastringer aclusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics
AT johnrkoethe clusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics
AT andrewowestfall clusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics
AT dorakluhanga clusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics
AT ginamclark clusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics
AT jasondgoldman clusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics
AT priscillalmulenga clusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics
AT ronaldacantrell clusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics
AT benjaminhchi clusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics
AT isaaczulu clusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics
AT michaelssaag clusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics
AT jeffreysastringer clusterrandomizedtrialofroutinehiv1viralloadmonitoringinzambiastudydesignimplementationandbaselinecohortcharacteristics
_version_ 1724996150828728320